- Home
- WPRT vs AVTX Comparison
WPRT vs AVTX Comparison
Compare WPRT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPRT
- AVTX
- Stock Information
- Founded
- WPRT 1995
- AVTX 2011
- Country
- WPRT Canada
- AVTX United States
- Employees
- WPRT N/A
- AVTX N/A
- Industry
- WPRT Industrial Machinery/Components
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- WPRT Industrials
- AVTX Health Care
- Exchange
- WPRT Nasdaq
- AVTX Nasdaq
- Market Cap
- WPRT 51.1M
- AVTX 57.4M
- IPO Year
- WPRT 1995
- AVTX 2015
- Fundamental
- Price
- WPRT $2.76
- AVTX $4.25
- Analyst Decision
- WPRT Buy
- AVTX Strong Buy
- Analyst Count
- WPRT 3
- AVTX 6
- Target Price
- WPRT $6.33
- AVTX $34.20
- AVG Volume (30 Days)
- WPRT 15.5K
- AVTX 66.4K
- Earning Date
- WPRT 05-13-2025
- AVTX 05-20-2025
- Dividend Yield
- WPRT N/A
- AVTX N/A
- EPS Growth
- WPRT N/A
- AVTX N/A
- EPS
- WPRT N/A
- AVTX N/A
- Revenue
- WPRT $302,299,000.00
- AVTX $441,000.00
- Revenue This Year
- WPRT N/A
- AVTX N/A
- Revenue Next Year
- WPRT N/A
- AVTX N/A
- P/E Ratio
- WPRT N/A
- AVTX N/A
- Revenue Growth
- WPRT N/A
- AVTX N/A
- 52 Week Low
- WPRT $2.50
- AVTX $4.15
- 52 Week High
- WPRT $6.60
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- WPRT 40.47
- AVTX 31.02
- Support Level
- WPRT $2.65
- AVTX $4.80
- Resistance Level
- WPRT $3.00
- AVTX $5.26
- Average True Range (ATR)
- WPRT 0.12
- AVTX 0.45
- MACD
- WPRT 0.03
- AVTX 0.03
- Stochastic Oscillator
- WPRT 31.43
- AVTX 11.96
About WPRT Westport Fuel Systems Inc
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).